Skip to content

Doximity

US · DOCS #2122 by market cap Listed 2021
28.73 -0.88 -2.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 29.00 -2.06%
After-hours 28.46 -0.94%
Overnight 29.49 -0.41%
34.6719.5228.732026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on DOCS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -13.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 3.9% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 39.9x Better than 14%
Forward P/E 43.4x Better than 9%
Price / Sales 9.0x Better than 11%
P/E vs own 5-yr range 47th pctl Better than 62%
Growth A-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.5% Better than 76%
Net income CAGR (3Y) 20.2% Better than 73%
Free cash flow CAGR (3Y) 22.3% Better than 67%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 89.1% Better than 96%
Operating margin 33.3% Better than 92%
Net margin 30.4% Better than 91%
Return on equity 19.3% Better than 77%
Return on invested capital 16.3% Better than 84%
Momentum B-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 13.4% Better than 93%
6-month return 44.1% Better than 94%
12-month return (ex latest month) -33.8% Better than 7%
Distance below 52-week high 44.6% Better than 24%
Financial Health A+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 6.1x Better than 89%
Debt to assets 0.9% Better than 93%
Free cash flow / net income 161.9% Better than 69%
Analyst View D

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 40.0% Better than 21%
Upside to average target 4.0% Better than 7%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -13.83%
1M -13.85%
3M +10.76%
6M +44.66%
YTD -35.12%
1Y -38.11%
3Y +17.65%
5Y -53.06%

Key statistics

Price & volume

Prev close
29.61
Open
29.32
Day range
28.55 - 29.86
Avg price
28.92
Volume
2.38M
Turnover
68.85M
Amplitude
4.42%
52-week range
17.15 - 51.85

Valuation

P/E
29.32
P/E (TTM)
39.90
P/B
5.52
EPS
0.98
Net profit
174.84M
Net assets
928.44M

Share structure

Market cap
5.13B
Float cap
3.56B
Shares out
178.41M
Float shares
123.77M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-06-24
52-week range 33% of range
17.15 51.85

44.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+22.00M net over the window

Short interest

Shares short
6.95M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Doximity (DOCS)?

Doximity last traded at 28.73. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Doximity's market cap?

About 5.13B.

What is the P/E ratio of Doximity?

The trailing twelve-month P/E is 39.90, below its own 5-year average of 48.80 — in the middle of its historical range (47.45% percentile). See the Valuation tab for the full history.

Does Doximity pay a dividend?

Doximity does not currently pay a regular dividend.

Is Doximity a buy according to analysts?

The consensus of 10 analysts is a Hold rating, with an average 12-month price target of 29.88, which implies 4.0% upside from the current price. This is not investment advice.

What is Doximity's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Doximity a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:01:27 · For reference only, not investment advice and not tailored to your situation.

Doximity discussion 0 comments

Add a comment